Hypermethylated NFE2L3 is associated with invasive breast cancer; NFE2L3 displays hypermethylation for estrogen receptor positive tumors and hypomethylation for estrogen receptor negative tumors. Here, NFE2L3 is linked to invasive breast carcinoma.